Exploration of the Prediction of the Survival Cycle and Influencing Factors of Chinese Patients With Advanced Cancer Based on Multi-Model Analysis.

Authors

Li Jiang, Wangdong Fan, Chuan Zhang

Published in

Medical science monitor : international medical journal of experimental and clinical research. Volume 32. Pages e953365. Aug 18, 2026. Epub Aug 18, 2026.

Abstract

BACKGROUND Accurate prediction of survival in patients with advanced cancer is essential for optimizing end-of-life care and allocating palliative resources. However, fragmented clinical data and limited prognostic tools make reliable survival estimation challenging in real-world clinical practice. MATERIAL AND METHODS This retrospective study analyzed data from 842 patients with advanced cancer admitted to the palliative care department of a tertiary hospital in China between 2018 and 2020. Multiple clinical and laboratory indicators were collected, including electrolyte levels, hematological parameters, and biochemical markers. Survival prediction models were developed using traditional Cox regression, LASSO-Cox regression, and forward likelihood ratio (Forward-LR) Cox regression, with 80% of the dataset used for training and 20% for validation. Model performance was evaluated using receiver operating characteristic (ROC) curves and area under the ROC curve (AUC) values for predicting survival at 1 to 4 weeks. RESULTS The median survival time of the cohort was 9.7 days, with most patients dying within 4 weeks. Age significantly influenced survival risk (HR=1.010). Several clinical indicators were independently associated with mortality, including potassium, chloride, iron, magnesium, platelet count, and inflammatory markers. Elevated potassium and iron levels increased mortality risk, whereas higher chloride and platelet levels showed protective effects. In model comparisons, LASSO-Cox demonstrated better performance in short-term survival prediction (1-2 weeks), while Forward-LR Cox regression showed superior accuracy for longer-term prediction (3-4 weeks). CONCLUSIONS A multi-model prognostic framework based on routine clinical indicators can effectively predict short-term survival in advanced cancer patients. These models may support clinical decision-making in palliative care and improve end-of-life resource allocation pending external validation.

PMID:
42608891
Bibliographic data and abstract were imported from PubMed on 18 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.